乱用薬物（DOA）検査の世界市場レポート 2025年

乱用薬物（DOA）検査市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.9％で、116億7,000万米ドルに成長します。予測期間の成長は、スポーツや陸上競技の検査拡大、意識と教育の向上、薬物関連犯罪の増加、企業のウェルネスプログラム、検査方法の進歩などに起因すると考えられます。予測期間における主な動向には、ポータブルおよびハンドヘルド検査機器の使用、検査室情報管理システム（LIMS）の導入、合成薬物検査の重視、大麻検査需要の増加、結果解釈のための人工知能（AI）の統合などがあります。

薬物乱用治療に対する需要の高まりが、乱用薬物（DOA）検査市場の成長を牽引すると予想されます。薬物乱用（物質乱用）には、個人や他人に有害な量の物質を使用することが含まれます。薬物検査は、最初のスクリーニング検査に続いて、特定の化合物の存在を検出・検証するための確認検査を通じて、これらの物質を特定するのに役立ちます。薬物乱用治療の需要が高まるにつれ、DOA検査の必要性も高まっています。例えば、2023年12月、英国を拠点とする政府プラットフォームである英国政府（GOV.UK）は、2022年4月から2023年3月の間に、290,635人の成人が薬物・アルコールサービスにアクセスし、前年の289,215人からわずかに増加したと報告しました。治療入院も増加し、137,749人が入院した（前年は130,490人、133,704人）。このように、薬物乱用治療に対する需要の高まりが、DOA検査市場の拡大を後押ししています。

病院に対する需要の高まりは、乱用薬物（DOA）検査市場の拡大を牽引すると予測されます。総合的なヘルスケア機関である病院は、病気や怪我に直面している人々に幅広い医療サービス、治療、ケアを提供する上で重要な役割を果たしています。乱用薬物（DOA）検査を病院内に統合することで、薬物乱用の早期発見、オーダーメイドの治療計画、臨床判断の強化、患者の安全確保、公衆衛生、職場の安全性、効率的な医療資源の活用に貢献します。2023年8月現在、英国には1148の病院があると報告されており、病院がヘルスケアサービスで果たす役割の大きさを強調しています。したがって、病院需要の増加が乱用薬物（DOA）検査市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界乱用薬物（DOA）検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の乱用薬物（DOA）検査市場：成長率分析
• 世界の乱用薬物（DOA）検査市場の実績：規模と成長, 2019-2024
• 世界の乱用薬物（DOA）検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界乱用薬物（DOA）検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の乱用薬物（DOA）検査市場製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アナライザー
• 迅速検査装置
• 消耗品
• ラボサービス
• 世界の乱用薬物（DOA）検査市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 尿
• 髪
• 口腔液
• 呼吸
• 世界の乱用薬物（DOA）検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理
• 刑事司法
• 職場スクリーニング
• 世界の乱用薬物（DOA）検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• 法医学研究所
• その他のエンドユーザー
• 世界の乱用薬物（DOA）検査市場、分析装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定分析装置
• クロマトグラフィーベースの分析装置
• 質量分析システム
• 世界の乱用薬物（DOA）検査市場、迅速検査装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 尿検査キット
• 唾液検査キット
• 毛髪検査キット
• 世界の乱用薬物（DOA）検査市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テストストリップ
• 試薬
• サンプル収集装置
• 世界の乱用薬物（DOA）検査市場、検査サービスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 毒性試験
• 確認テスト
• スクリーニングサービス

第7章 地域別・国別分析

• 世界の乱用薬物（DOA）検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の乱用薬物（DOA）検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 乱用薬物（DOA）検査市場：競合情勢
• 乱用薬物（DOA）検査市場：企業プロファイル
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Laboratory Corporation of America Holdings
• Quest Diagnostics Inc.
• bioMerieux Inc.
• Dragerwerk AG & Co. KGaA
• Aegis Sciences Corporation
• NMS Labs
• Clinical Reference Laboratory Inc.
• Cordant Health Solutions
• Millennium Health
• ACM Global Laboratories
• Psychemedics Corporation
• Alfa Scientific Designs Inc.
• Alere Toxicology Services
• Omega Laboratories Inc.
• BioTek Laboratories

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 乱用薬物（DOA）検査市場2029：新たな機会を提供する国
• 乱用薬物（DOA）検査市場2029：新たな機会を提供するセグメント
• 乱用薬物（DOA）検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug of abuse (DOA) testing involves examining substances, such as drugs, chemicals, or plant products, typically used recreationally. This includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are screened for on a drug panel. Clinical screening methods use the patient's urine, saliva, blood, hair, or sweat for this purpose.

Drug of Abuse (DOA) testing encompasses various products and services, including analyzers, rapid testing devices, consumables, and laboratory services. Analyzers, automatic devices measuring chemical concentrations, play a crucial role in this domain. The testing involves sample types such as urine, hair, oral fluid, and breath, with applications in pain management, criminal justice, and workplace screening. End-users of DOA testing include hospitals, diagnostic laboratories, forensic laboratories, and other relevant entities.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs of abuse (DOA) testing market size has grown strongly in recent years. It will grow from $7.3 billion in 2024 to $7.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to government regulations and workplace policies, pre-employment screening, law enforcement and legal procedures, drug rehabilitation programs, transportation industry compliance.

The drugs of abuse (DOA) testing market size is expected to see strong growth in the next few years. It will grow to $11.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to expanding sports and athletics testing, increasing awareness and education, rise in drug-related crimes, corporate wellness programs, advancements in testing methods. Major trends in the forecast period include use of portable and handheld testing devices, implementation of laboratory information management systems (LIMS), emphasis on synthetic drug testing, increasing demand for cannabis testing, integration of artificial intelligence (AI) for result interpretation.

The rising demand for drug abuse treatment is expected to drive the growth of the drugs of abuse (DOA) testing market. Drug abuse, or substance abuse, involves using substances in quantities harmful to the individual or others. Drug testing helps identify these substances through an initial screening test followed by confirmatory testing to detect and validate the presence of specific compounds. As the demand for drug abuse treatment increases, the need for DOA testing also grows. For example, in December 2023, the Government of the United Kingdom (GOV.UK), a UK-based government platform, reported that between April 2022 and March 2023, 290,635 adults accessed drug and alcohol services, up slightly from 289,215 in the previous year. Treatment admissions also increased, with 137,749 individuals admitted compared to 130,490 and 133,704 in the two preceding years. Thus, the growing demand for drug abuse treatment is driving the expansion of the DOA testing market.

The growing demand for hospitals is anticipated to drive the expansion of the drugs of abuse (DOA) testing market. Hospitals, as comprehensive healthcare institutions, play a crucial role in delivering a broad spectrum of medical services, treatment, and care for individuals facing illness or injury. The integration of drugs of abuse (DOA) testing within hospitals facilitates early detection of substance abuse, enabling customized treatment plans, enhancing clinical decision-making, ensuring patient safety, and contributing to public health, workplace safety, and efficient healthcare resource utilization. As of August 2023, there are reported to be 1148 hospitals in the UK, emphasizing the significant role hospitals play in healthcare services. Hence, the increasing demand for hospitals is a key factor propelling the growth of the drugs of abuse (DOA) testing market.

Major players in the drugs of abuse (DOA) testing market are directing their efforts towards developing cutting-edge products, including software-as-a-service (SaaS) platforms, to reinforce their market presence. Software-as-a-Service (SaaS) represents a software distribution model where applications are hosted by a third-party provider and accessed by customers over the internet. A notable example is the introduction of the Addison drug discovery software by Merck KGaA, a US-based science and technology company, in December 2023. This software accelerates drug development and enhances the success rate of novel medications and therapies by integrating computer-aided drug design, machine learning, and generative AI. Addison provides recommendations on optimal methods for synthesizing medications, bridging the gap between virtual molecule design and practical manufacturability. By extracting hidden insights from extensive datasets, the platform increases the likelihood of patients benefiting from innovative treatments.

Key players in the drugs of abuse (DOA) testing market are actively introducing new products, including advanced drug testing, to stay ahead in the market competition. Drug testing involves analyzing biological specimens, such as urine, to identify specific drugs or their metabolites. In December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services, launched urine drugs of abuse testing services. These services are known for their ease of use, rapid effects, and affordability. The laboratory provides accredited urine drug testing services, ensuring high quality and precision in test results. Serving over 6,000 clients worldwide, the organization employs both screening and confirmatory testing in urine drug abuse testing services to ensure the accuracy and reliability of the results.

In June 2024, Premier Biotech Inc., a biotechnology company based in the United States, acquired Desert Tox LLC for an undisclosed sum. This acquisition aims to expand Premier Biotech's portfolio of cost-effective drug misuse screening solutions, enhancing the accessibility and efficiency of its drug testing services. Desert Tox LLC, also based in the United States, specializes in toxicology and drug testing solutions, further strengthening Premier Biotech's capabilities in this sector.

Major companies operating in the drugs of abuse (DOA) testing market include Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMerieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

North America was the largest region in the drugs of abuse (DOA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs of Abuse (DOA) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (doa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
• 2) By Sample Type: Urine; Hair; Oral Fluid; Breath
• 3) By Application: Pain Management; Criminal Justice; Workplace Screening
• 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
• Subsegments:
• 1) By Analyzers: Immunoassay Analyzers; Chromatography-Based Analyzers; Mass Spectrometry Systems
• 2) By Rapid Testing Devices: Urine Test Kits; Saliva Test Kits; Hair Test Kits
• 3) By Consumables: Test Strips; Reagents; Sample Collection Devices
• 4) By Laboratory Services: Toxicology Testing; Confirmation Testing; Screening Services
• Companies Mentioned: Siemens AG; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drugs of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drugs of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drugs of Abuse (DOA) Testing Market Growth Rate Analysis
• 5.4. Global Drugs of Abuse (DOA) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drugs of Abuse (DOA) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drugs of Abuse (DOA) Testing Total Addressable Market (TAM)

6. Drugs of Abuse (DOA) Testing Market Segmentation

• 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analyzers
• Rapid Testing Devices
• Consumables
• Laboratory Services
• 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urine
• Hair
• Oral Fluid
• Breath
• 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management
• Criminal Justice
• Workplace Screening
• 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories
• Other End Users
• 6.5. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Analyzers
• Chromatography-Based Analyzers
• Mass Spectrometry Systems
• 6.6. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urine Test Kits
• Saliva Test Kits
• Hair Test Kits
• 6.7. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Strips
• Reagents
• Sample Collection Devices
• 6.8. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Toxicology Testing
• Confirmation Testing
• Screening Services

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

• 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

• 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

• 9.1. China Drugs of Abuse (DOA) Testing Market Overview
• 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

• 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

• 11.1. Japan Drugs of Abuse (DOA) Testing Market Overview
• 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

• 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

• 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

• 14.1. South Korea Drugs of Abuse (DOA) Testing Market Overview
• 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

• 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
• 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

• 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

• 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

• 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drugs of Abuse (DOA) Testing Market

• 19.1. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drugs of Abuse (DOA) Testing Market

• 20.1. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drugs of Abuse (DOA) Testing Market

• 21.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
• 21.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drugs of Abuse (DOA) Testing Market

• 22.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drugs of Abuse (DOA) Testing Market

• 23.1. North America Drugs of Abuse (DOA) Testing Market Overview
• 23.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drugs of Abuse (DOA) Testing Market

• 24.1. USA Drugs of Abuse (DOA) Testing Market Overview
• 24.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drugs of Abuse (DOA) Testing Market

• 25.1. Canada Drugs of Abuse (DOA) Testing Market Overview
• 25.2. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drugs of Abuse (DOA) Testing Market

• 26.1. South America Drugs of Abuse (DOA) Testing Market Overview
• 26.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drugs of Abuse (DOA) Testing Market

• 27.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drugs of Abuse (DOA) Testing Market

• 28.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
• 28.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drugs of Abuse (DOA) Testing Market

• 29.1. Africa Drugs of Abuse (DOA) Testing Market Overview
• 29.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

• 30.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
• 30.2. Drugs of Abuse (DOA) Testing Market Company Profiles
  • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drugs of Abuse (DOA) Testing Market Other Major And Innovative Companies

• 31.1. Laboratory Corporation of America Holdings
• 31.2. Quest Diagnostics Inc.
• 31.3. bioMerieux Inc.
• 31.4. Dragerwerk AG & Co. KGaA
• 31.5. Aegis Sciences Corporation
• 31.6. NMS Labs
• 31.7. Clinical Reference Laboratory Inc.
• 31.8. Cordant Health Solutions
• 31.9. Millennium Health
• 31.10. ACM Global Laboratories
• 31.11. Psychemedics Corporation
• 31.12. Alfa Scientific Designs Inc.
• 31.13. Alere Toxicology Services
• 31.14. Omega Laboratories Inc.
• 31.15. BioTek Laboratories

32. Global Drugs of Abuse (DOA) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

34. Recent Developments In The Drugs of Abuse (DOA) Testing Market

35. Drugs of Abuse (DOA) Testing Market High Potential Countries, Segments and Strategies

• 35.1 Drugs of Abuse (DOA) Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drugs of Abuse (DOA) Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drugs of Abuse (DOA) Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer